You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 20, 2024

CLINICAL TRIALS PROFILE FOR SODIUM TETRADECYL SULFATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Sodium Tetradecyl Sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01347294 ↗ Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations Unknown status Oslo University Hospital Phase 4 2011-08-01 The purpose of this study is to determine the effectiveness of bleomycin, fibrovein and bleomycin and fibrovein in the treatment of venous malformation.
NCT01408732 ↗ Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia Completed American Rhinologic Society Phase 1/Phase 2 2011-02-01 The purpose of this study is to test a novel and tolerable office-based treatment method, sclerotherapy with sodium tetradecyl sulfate, for recurrent epistaxis (nosebleeds) related to Hereditary Hemorrhagic Telangiectasia (HHT) disease.
NCT01408732 ↗ Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia Completed University of Minnesota Phase 1/Phase 2 2011-02-01 The purpose of this study is to test a novel and tolerable office-based treatment method, sclerotherapy with sodium tetradecyl sulfate, for recurrent epistaxis (nosebleeds) related to Hereditary Hemorrhagic Telangiectasia (HHT) disease.
NCT01408732 ↗ Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia Completed University of Minnesota - Clinical and Translational Science Institute Phase 1/Phase 2 2011-02-01 The purpose of this study is to test a novel and tolerable office-based treatment method, sclerotherapy with sodium tetradecyl sulfate, for recurrent epistaxis (nosebleeds) related to Hereditary Hemorrhagic Telangiectasia (HHT) disease.
NCT03311269 ↗ A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency Recruiting Vascular Insights, LLC Phase 2 2017-09-22 VICARES is a prospective randomized, controlled, multi-center, double blind study treating venous insufficiency associated with incompetent saphenous veins with 1% and 3% Sodium Tetradecyl Sulfate (STS) solution utilizing the ClariVein system.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sodium Tetradecyl Sulfate

Condition Name

Condition Name for Sodium Tetradecyl Sulfate
Intervention Trials
Cosmesis 1
Venous Insufficiency 1
Cost Effectiveness 1
Venous Malformation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sodium Tetradecyl Sulfate
Intervention Trials
Ulcer 1
Esophageal and Gastric Varices 1
Venous Insufficiency 1
Epidermal Cyst 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sodium Tetradecyl Sulfate

Trials by Country

Trials by Country for Sodium Tetradecyl Sulfate
Location Trials
United States 7
Finland 1
Taiwan 1
Pakistan 1
Norway 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sodium Tetradecyl Sulfate
Location Trials
Pennsylvania 1
Washington 1
New Jersey 1
Massachusetts 1
Maryland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sodium Tetradecyl Sulfate

Clinical Trial Phase

Clinical Trial Phase for Sodium Tetradecyl Sulfate
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 2 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sodium Tetradecyl Sulfate
Clinical Trial Phase Trials
Recruiting 4
Completed 2
Unknown status 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sodium Tetradecyl Sulfate

Sponsor Name

Sponsor Name for Sodium Tetradecyl Sulfate
Sponsor Trials
University of Minnesota - Clinical and Translational Science Institute 1
Vascular Insights, LLC 1
American College of Phlebology 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sodium Tetradecyl Sulfate
Sponsor Trials
Other 11
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.